Written by Steve Cannon for USSA News.
Key Takeaways:
- Bromelain and acetylcysteine (BromAc) may neutralize the harmful properties of spike proteins
- The combination of the two supplements showed significant protein alteration in vitro
- Clinical testing is imminent to determine if the results can be achieved in human subjects
- BromAc may be an effective therapeutic agent for early SARS-CoV-2 infection and even have potential as a prophylactic
A recent study published in the journal Viruses suggests that simple nutrition may mitigate the damaging effects of spike proteins in Covid vaccines. Australian researchers looked at two common nutritional supplements, bromelain and acetylcysteine (BromAc), that could unfold the structures that hold spike proteins together, effectively neutralizing them.
BromAc’s Effect on Spike Proteins
The team found that a BromAc treatment is capable of reducing or even eliminating the ability of spike proteins to cause Covid infection by breaking apart the glycosidic linkages and disulfide bonds. Combining the two supplements at specific levels resulted in the destabilization and unraveling of Covid spike proteins.
Clinical Testing
While the tests were conducted in vitro, more study is needed to determine if the same results can be achieved in actual human subjects. Clinical testing through nasal administration in patients with early SARS-CoV-2 infection is imminent.
Potential as a Therapeutic Agent The authors note that BromAc may be an effective therapeutic agent for early SARS-CoV-2 infection, despite mutations, and even have potential as a prophylactic in people at high risk of infection.
Encouraging Results
The results of the study are “encouraging” and point to a natural solution for Covid spike proteins that otherwise outsmart most other potential remedies. There is currently no suitable therapeutic treatment for early SARS-CoV-2 aimed at preventing disease progression.
FAQ
Q: What is BromAc?
A: BromAc is a combination of the two supplements, bromelain and acetylcysteine.
Q: Does BromAc work against Covid spike proteins?
A: In vitro tests have shown that BromAc may neutralize the harmful properties of spike proteins. Clinical testing is needed to determine if the results can be achieved in human subjects.
Q: Is BromAc a suitable therapeutic treatment for early SARS-CoV-2 infection?
A: The authors of the study believe that BromAc may be an effective therapeutic agent for early SARS-CoV-2 infection, despite mutations, and even have potential as a prophylactic in people at high risk of infection.